|
Re: Wonderful
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 08:48PM
|
|
Re: We Need The Futility Analysis
|
4
|
Resverlogix Corp.
|
Feb 08, 2018 11:52AM
|
|
Re: $100 million dollar question
|
4
|
Resverlogix Corp.
|
Jun 13, 2017 04:43PM
|
|
Re: Micheal Sweeney ( disgruntled employee) ...
|
4
|
Resverlogix Corp.
|
Apr 09, 2016 10:04AM
|
|
Re: Update
|
4
|
Resverlogix Corp.
|
Jul 12, 2017 02:59PM
|
|
Re: K2
|
4
|
Resverlogix Corp.
|
Apr 11, 2021 06:05PM
|
|
Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
|
4
|
Resverlogix Corp.
|
Sep 08, 2021 10:58AM
|
|
Metablock
|
4
|
Resverlogix Corp.
|
Dec 06, 2021 11:16AM
|
|
Re: Vas. Dementia pipeline RVX?
|
4
|
Resverlogix Corp.
|
Dec 07, 2022 11:24AM
|
|
Re: My estimate for Top Line Data Announcement...is a shocker!
|
4
|
Resverlogix Corp.
|
Jun 08, 2019 12:56PM
|
|
Re: Another RVX-208 Poster at IAS 2015 May 26
|
4
|
Resverlogix Corp.
|
May 19, 2015 02:49PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 13, 2022 12:16PM
|
|
Buying opportunity
|
4
|
Resverlogix Corp.
|
Jun 16, 2017 04:02PM
|
|
Re: Zenith prezzy
|
4
|
Zenith Epigenetics
|
Jun 24, 2017 10:39AM
|
|
Re: Interesting Uptick
|
4
|
Resverlogix Corp.
|
Apr 28, 2016 01:44PM
|
|
Re: Pretty much as expected
|
4
|
Resverlogix Corp.
|
Sep 17, 2019 12:43PM
|
|
Re: Zenith-Oncology Pipeline
|
4
|
Zenith Epigenetics
|
Mar 19, 2021 11:19AM
|
|
Re: First Dosing v "Actively Recruiting" ?
|
4
|
Resverlogix Corp.
|
Nov 12, 2021 11:33AM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
4
|
Zenith Epigenetics
|
Aug 17, 2017 07:13PM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
4
|
Resverlogix Corp.
|
Aug 15, 2022 07:08PM
|
